High Content Screening Market worth $615.8 Million by 2018 - New Report by MarketsandMarkets

The global high content screening market is segmented on the basis of products, applications, end users, and geography. The High Content Screening Market is expected to witness a high growth in the forecast period; http://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
MarketsandMarkets

MarketsandMarkets

Major Players are Thermo Fisher Scientific (U.S.), Molecular Devices (U.S.), Perkin Elmer (U.S.), GE Healthcare Lifesciences (U.K), and Merck Millipore (Germany)

(PRWEB) May 03, 2014

The “High Content Screening Market by Instruments (Cell Imaging and Analysis System) by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018” analyzes and studies the major market drivers, restraints, andopportunities in North America, Europe, Asia, and the Rest of the World (RoW).

Browse more than 50 market data tables with 10 figures spread through 151 pages and in-depth TOC on "High Content Screening Market"

http://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html

Early buyers will receive 10% customization on this report.

This report studies the global high content screening market over the forecast period of 2013 to 2018. The global high content screening market was valued at an estimated $362.2 million in 2013 and is expected to reach $615.8 million by 2018, growing at a CAGR of 11.2% from 2013 to 2018.

Ask for Free PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=42710391.

Enhanced accuracy of cell imaging and analysis systems helps in reducing the drug discovery time period and costs, which is a major factor driving the growth of this market. Furthermore, the increasing use of HCS in toxicity studies in the early phase of drug discovery is another factor that propels the growth of this market. Government support for the growth of innovative technologies and rising demand for outsourcing of drug discovery services, especially in the Asian region, are also major reasons for the high growth of this market. Based on HCS products, the instruments market commanded the largest share of 43% in 2013. However, the HCS software market is poised to grow at the highest CAGR from 2013 to 2018.

Inquire Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=42710391.

The global HCS market is a technology-driven market. Over the years, the technologies used as well as their adoption by contract research organizations (CROs) and academic and government institutes have witnessed a rapid change. The market demands significant investments in R&D in order to constantly come up with new innovative products and technologies. Through the development of innovative products, the players in the HCS market compete against each other in order to enhance their market shares.

A number of small and mid-sized emerging players and large players are present in the global HCS market.The degree of competiveness amongst these players is high. Moreover, many new players are entering this market, which is increasing the level of competition. At the same time, existing players are focusing on increasing their product differentiation to reduce competition and maintain their market share.

The HCS consumables market does not have a market leader as the market is fragmented and is shared by many different players. Some of the prominent players in the HCS consumables market are Life Technologies (U.S.), Thermo Fisher Scientific (U.S.), Becton, Dickinson and Company (U.S.), Molecular Devices (U.S.), Cell Signaling Technologies (U.S.), PerkinElmer (U.S.), GE Healthcare (U.K.), Intellicyt Corporation (U.S.), and Merck KGaA (U.S.).

Browse Related Reports:

High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (UHTS), Label Free, Bioinformatics), by Applications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018

http://www.marketsandmarkets.com/Market-Reports/high-throughput-screening-market-134981950.html

Chromatography Instrumentation Market by Systems [LC (HPLC, UHPLC, FLASH), GC, TLC, SFC, Others (Autosamplers, Detectors, Fraction collectors)], by Consumables (Reverse phase columns, Syringe filters, Vials) & Industry - Global Forecast to 2018

http://www.marketsandmarkets.com/Market-Reports/chromatography-instrumentation-market-1258.html

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets


Contact

Follow us on: Contact's Google Plus